
Sign up to save your podcasts
Or
Heather Turner, CEO at Carmot Therapeutics, speaks with Venrock partner Nimish Shah to discuss her time as CEO. Turner shares how she guided the company through its acquisition by Roche, advice for other CEOs on the verge of an acquisition, her perspective on the GLP-1 market and what excites her about the future of biotech.
4.8
6262 ratings
Heather Turner, CEO at Carmot Therapeutics, speaks with Venrock partner Nimish Shah to discuss her time as CEO. Turner shares how she guided the company through its acquisition by Roche, advice for other CEOs on the verge of an acquisition, her perspective on the GLP-1 market and what excites her about the future of biotech.
1,272 Listeners
2,184 Listeners
1,022 Listeners
989 Listeners
1,780 Listeners
2,300 Listeners
3,982 Listeners
123 Listeners
316 Listeners
5,916 Listeners
1,537 Listeners
30 Listeners
146 Listeners
9 Listeners
45 Listeners